Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$133K Buy
1,123
+1,089
+3,203% +$126K 0.06% 342
2026
Q1
$4.07K Sell
34
-16
-32% -$2.1K ﹤0.01% 1678
2025
Q4
$6.81K Sell
50
-60
-55% -$8.63K ﹤0.01% 1306
2025
Q3
$16.2K Buy
110
+70
+175% +$9.71K 0.01% 970
2025
Q2
$5.17K Buy
+40
New +$4.84K ﹤0.01% 1042

Other funds holding XYL

Essential Partners's XYL Position: Q2 2026 in Review

Essential Partners increased its Xylem (XYL) stake by 3,203% in Q2 2026, buying an estimated $126K and bringing the position to 1,123 shares worth $133K. The position accounts for 0.06% of the portfolio, ranked #342.

Essential Partners first reported a position in XYL in Q2 2025 and has held it in 5 quarters since. 1,096 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Essential Partners held 1,123 shares of Xylem worth $133K as of Q2 2026.
  • Essential Partners bought 1,089 Xylem shares in Q2 2026, an estimated $126K.
  • Xylem made up 0.06% of Essential Partners's portfolio in Q2 2026, its #342 holding.
  • Essential Partners first reported a position in Xylem in Q2 2025 and has held it in 5 quarters since.
  • 1,096 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Essential Partners's 13F filing for Q2 2026, filed 10 Aug 2026.